ABCELLERA BIOLOGICS (8QQ) — Long-term Investment Intensity
ABCELLERA BIOLOGICS (8QQ) has a Long-term Investment Intensity of 4.6% as of December 2025. Long-term investments of €62.58 Million represent 4.6% of total assets of €1.36 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 8QQ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ABCELLERA BIOLOGICS Long-term Investment Intensity (2021–2025)
This chart shows how ABCELLERA BIOLOGICS's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 4.6%, reflecting long-term investments of €62.58 Million against total assets of €1.36 Billion EUR. Explore 8QQ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for ABCELLERA BIOLOGICS (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for ABCELLERA BIOLOGICS from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ABCELLERA BIOLOGICS (8QQ) total market value.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.6% | €62.58 Million | €1.36 Billion | ▼ -1.4 pp |
| 2024 | 6.0% | €82.30 Million | €1.36 Billion | ▲ +1.6 pp |
| 2023 | 4.4% | €65.94 Million | €1.49 Billion | ▼ -0.3 pp |
| 2022 | 4.7% | €72.52 Million | €1.54 Billion | ▲ +0.9 pp |
| 2021 | 3.8% | €50.31 Million | €1.32 Billion | — |